Kevin Bitter is Senior Vice President of Strategy and Corporate Development, bringing extensive experience partnering with executive leadership to drive corporate strategy, capital formation, and business development in the biopharmaceutical industry. He has supported the raising of over $500M in financings and the execution of multiple strategic partnerships, including two completed M&A transactions. Most recently, […]
Archives for Management TeamPublications & Posters
VIEW:
The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.
Barbara Wirostko, MD, FARVO
Barbara Wirostko, MD, FARVO is Chief Medical Officer and Co-Founder of Qlaris Bio. As a serial entrepreneur and passionate advocate for patients’ needs in ophthalmology, she is responsible for guiding all Qlaris Bio’s medical and clinical development strategy. In addition to her role at Qlaris Bio, she is a practicing glaucoma clinician researcher, holding an […]
Fred Guerard, Pharm.D.
Fred Guerard, Pharm.D. joins Qlaris as President and Chief Executive Officer. Dr. Guerard brings more than two decades of global leadership experience in ophthalmology and biotechnology, with a track record of advancing innovative therapies through late-stage development and toward commercialization. Dr. Guerard most recently served as CEO of Opthea, where he strengthened the company’s strategic […]